Skip to main content

Find Clinical Trials

Home
Conditions
PIK3CA-related Overgrowth Spectrum

Clinical trial condition

PIK3CA-related Overgrowth Spectrum

Explore clinical trials studying PIK3CA-related Overgrowth Spectrum. Study availability and eligibility vary by location and protocol.

4 public trials 1 recruiting study

Refine in advanced search Browse all conditions

PIK3CA-related Overgrowth Spectrum trial results

Recruiting

A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations

NCT05983159

Conditions: Arteriovenous Malformation (AVM), Arteriovenous Malformations, Cardiovascular Abnormalities, +30 more
Locations: Peter MacCallum Cancer Centre Parkville, Victoria, Australia

The Royal Children's Hospital Parkville, Victoria, Australia

View Trial Details

Completed

National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS)

NCT05563831

Conditions: Angiomatosis, CLOVES Syndrome, Cardiovascular Abnormalities, +32 more
Locations: Translational medicine and Targeted therapies unit, Hôpital Necker Enfants Malades Paris, France

View Trial Details

Completed

A Study of the Epidemiology and Hospital Management of Patients With PROS in France

NCT07222423

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +9 more
Locations: Novartis East Hanover, New Jersey, United States

View Trial Details

Completed

Health-related Quality of Life, Symptom Severity, and Pain Among Patients With PIK3CA-related Overgrowth Spectrum: A Mixed-methods Observational Study

NCT05294289

Conditions: PIK3CA-related Overgrowth Spectrum
Locations: Novartis Investigative Site East Hanover, New Jersey, United States

View Trial Details